- Home
- RVPH vs NDLS Comparison
RVPH vs NDLS Comparison
Compare RVPH & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- NDLS
- Stock Information
- Founded
- RVPH 2006
- NDLS 1995
- Country
- RVPH United States
- NDLS United States
- Employees
- RVPH N/A
- NDLS N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- NDLS Restaurants
- Sector
- RVPH Health Care
- NDLS Consumer Discretionary
- Exchange
- RVPH Nasdaq
- NDLS Nasdaq
- Market Cap
- RVPH 32.8M
- NDLS 32.9M
- IPO Year
- RVPH N/A
- NDLS 2013
- Fundamental
- Price
- RVPH $0.38
- NDLS $0.80
- Analyst Decision
- RVPH Strong Buy
- NDLS Strong Buy
- Analyst Count
- RVPH 5
- NDLS 2
- Target Price
- RVPH $9.00
- NDLS $3.00
- AVG Volume (30 Days)
- RVPH 2.8M
- NDLS 212.2K
- Earning Date
- RVPH 08-13-2025
- NDLS 08-06-2025
- Dividend Yield
- RVPH N/A
- NDLS N/A
- EPS Growth
- RVPH N/A
- NDLS N/A
- EPS
- RVPH N/A
- NDLS N/A
- Revenue
- RVPH N/A
- NDLS $495,670,000.00
- Revenue This Year
- RVPH N/A
- NDLS $5.37
- Revenue Next Year
- RVPH N/A
- NDLS $0.68
- P/E Ratio
- RVPH N/A
- NDLS N/A
- Revenue Growth
- RVPH N/A
- NDLS N/A
- 52 Week Low
- RVPH $0.30
- NDLS $0.55
- 52 Week High
- RVPH $4.28
- NDLS $1.83
- Technical
- Relative Strength Index (RSI)
- RVPH 31.86
- NDLS 52.86
- Support Level
- RVPH $0.35
- NDLS $0.66
- Resistance Level
- RVPH $0.83
- NDLS $0.82
- Average True Range (ATR)
- RVPH 0.06
- NDLS 0.07
- MACD
- RVPH -0.02
- NDLS 0.01
- Stochastic Oscillator
- RVPH 14.45
- NDLS 87.67
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.